Corcept Therapeutics (CORT)

Feb 12, 2025, 4:05 PM EST - 10 days ago

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call

Jan 29, 2025, 7:37 AM EST - 24 days ago

Big Money Keeps Buying Corcept

Jan 24, 2025, 11:00 AM EST - 4 weeks ago

Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm

Jan 22, 2025, 2:03 PM EST - 4 weeks ago

Corcept Therapeutics Generating Strong Revenue And Profit Growth

Dec 30, 2024, 5:15 PM EST - 7 weeks ago

Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism

Dec 16, 2024, 8:00 AM EST - 2 months ago

Corcept's Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism

Dec 12, 2024, 4:05 PM EST - 2 months ago

Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing's Syndrome) and Difficult-to-Control Diabetes

Dec 11, 2024, 5:27 PM EST - 2 months ago

Corcept Therapeutics' ALS drug fails in mid-stage trial

Dec 11, 2024, 4:05 PM EST - 2 months ago

Corcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS)

Nov 27, 2024, 8:00 AM EST - 3 months ago

Corcept Therapeutics: A Most Promising And Compelling Biotech

Oct 30, 2024, 9:00 PM EDT - 4 months ago

Corcept Therapeutics Incorporated (CORT) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:05 PM EDT - 4 months ago

Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing's Syndrome and Provides Corporate Update

Oct 23, 2024, 4:05 PM EDT - 4 months ago

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call

Oct 15, 2024, 9:43 AM EDT - 4 months ago

Corcept: Key Announcements Coming Soon

Sep 30, 2024, 3:01 PM EDT - 5 months ago

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast

Sep 19, 2024, 12:54 PM EDT - 5 months ago

3 Small Biotech Stocks With The 'Big Mo' Right Now

AUPH VRDN

Sep 15, 2024, 11:40 AM EDT - 5 months ago

Corcept Therapeutics - Three Dynamic Catalysts To Reaccelerate Growth

Jul 30, 2024, 2:36 PM EDT - 7 months ago

Corcept Therapeutics: Q2 Gains Overshadowed By Generic Competition And Speculative Pipeline

Jul 29, 2024, 9:22 PM EDT - 7 months ago

Corcept Therapeutics Incorporated (CORT) Q2 2024 Earnings Call Transcript

Jul 22, 2024, 4:05 PM EDT - 7 months ago

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

Jul 17, 2024, 11:57 AM EDT - 7 months ago

These small-cap stocks score highest when screened for quality

CALX CARG CPRX GOGO MC MYRG PLMR

Jun 24, 2024, 4:15 PM EDT - 8 months ago

Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions

Jun 3, 2024, 8:00 AM EDT - 9 months ago

Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome)

May 1, 2024, 11:42 PM EDT - 10 months ago

Corcept Therapeutics Incorporated (CORT) Q1 2024 Earnings Call Transcript

May 1, 2024, 4:05 PM EDT - 10 months ago

Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update

Apr 24, 2024, 4:05 PM EDT - 10 months ago

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

Apr 1, 2024, 8:00 AM EDT - 11 months ago

Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing's Syndrome

Feb 15, 2024, 9:50 PM EST - 1 year ago

Corcept Therapeutics Incorporated (CORT) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 4:07 PM EST - 1 year ago

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update

Feb 15, 2024, 4:02 PM EST - 1 year ago

Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial

Feb 8, 2024, 4:05 PM EST - 1 year ago

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call

Jan 2, 2024, 7:06 AM EST - 1 year ago

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA)

MIST RPID

Nov 1, 2023, 8:44 PM EDT - 1 year ago

Corcept Therapeutics Incorporated (CORT) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 4:05 PM EDT - 1 year ago

Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update

Nov 1, 2023, 8:00 AM EDT - 1 year ago

Corcept Appoints Monica Tellado as President, Emerging Markets

Oct 26, 2023, 4:05 PM EDT - 1 year ago

Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)

Aug 26, 2023, 6:43 AM EDT - 1 year ago

Corcept Therapeutics: Far More Constructive With Korlym Resolve (Rating Upgrade)

Aug 2, 2023, 10:37 PM EDT - 1 year ago

Corcept Therapeutics Incorporated (CORT) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 4:05 PM EDT - 1 year ago

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Jul 17, 2023, 4:05 PM EDT - 1 year ago

Corcept's Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)

May 3, 2023, 11:43 PM EDT - 1 year ago

Corcept Therapeutics Incorporated (CORT) Q1 2023 Earnings Call Transcript

Apr 5, 2023, 4:05 PM EDT - 2 years ago

Corcept Therapeutics Announces Final Results of Tender Offer

Mar 28, 2023, 4:05 PM EDT - 2 years ago

Corcept Therapeutics Initiates CATALYST Clinical Trial

Feb 28, 2023, 7:59 PM EST - 2 years ago

Corcept Therapeutics Incorporated (CORT) Q4 2022 Earnings Call Transcript

Feb 28, 2023, 4:05 PM EST - 2 years ago

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update

Feb 14, 2023, 4:05 PM EST - 2 years ago

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call

Dec 16, 2022, 8:00 AM EST - 2 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses to Contact the Firm

Dec 15, 2022, 7:19 AM EST - 2 years ago

5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More - Corcept Therapeutics (NASDAQ:CORT), Cytek Biosciences (NASDAQ:CTKB)

CTKB